1317 related articles for article (PubMed ID: 26689709)
1. Immunosuppressive cells in tumor immune escape and metastasis.
Liu Y; Cao X
J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
[TBL] [Abstract][Full Text] [Related]
2. Immune cell promotion of metastasis.
Kitamura T; Qian BZ; Pollard JW
Nat Rev Immunol; 2015 Feb; 15(2):73-86. PubMed ID: 25614318
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia and acidosis: immune suppressors and therapeutic targets.
Damgaci S; Ibrahim-Hashim A; Enriquez-Navas PM; Pilon-Thomas S; Guvenis A; Gillies RJ
Immunology; 2018 Jul; 154(3):354-362. PubMed ID: 29485185
[TBL] [Abstract][Full Text] [Related]
4. The effect of tumor-derived exosomes on immune regulation and cancer immunotherapy.
Whiteside TL
Future Oncol; 2017 Dec; 13(28):2583-2592. PubMed ID: 29198150
[TBL] [Abstract][Full Text] [Related]
5. Reprogramming the Tumor Microenvironment to Improve Immunotherapy: Emerging Strategies and Combination Therapies.
Datta M; Coussens LM; Nishikawa H; Hodi FS; Jain RK
Am Soc Clin Oncol Educ Book; 2019 Jan; 39():165-174. PubMed ID: 31099649
[TBL] [Abstract][Full Text] [Related]
6. Epithelial-to-mesenchymal transition in cancer progression: unraveling the immunosuppressive module driving therapy resistance.
Singh D; Siddique HR
Cancer Metastasis Rev; 2024 Mar; 43(1):155-173. PubMed ID: 37775641
[TBL] [Abstract][Full Text] [Related]
7. Chemokines Modulate Immune Surveillance in Tumorigenesis, Metastasis, and Response to Immunotherapy.
Vilgelm AE; Richmond A
Front Immunol; 2019; 10():333. PubMed ID: 30873179
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms that drive inflammatory tumor microenvironment, tumor heterogeneity, and metastatic progression.
Yang L; Lin PC
Semin Cancer Biol; 2017 Dec; 47():185-195. PubMed ID: 28782608
[TBL] [Abstract][Full Text] [Related]
9. The Immune Landscape of Thyroid Cancer in the Context of Immune Checkpoint Inhibition.
Varricchi G; Loffredo S; Marone G; Modestino L; Fallahi P; Ferrari SM; de Paulis A; Antonelli A; Galdiero MR
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412566
[TBL] [Abstract][Full Text] [Related]
10. Role of Tumor-Mediated Dendritic Cell Tolerization in Immune Evasion.
DeVito NC; Plebanek MP; Theivanthiran B; Hanks BA
Front Immunol; 2019; 10():2876. PubMed ID: 31921140
[TBL] [Abstract][Full Text] [Related]
11. Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy.
Albini A; Bruno A; Noonan DM; Mortara L
Front Immunol; 2018; 9():527. PubMed ID: 29675018
[TBL] [Abstract][Full Text] [Related]
12. Combination Cancer Therapy with Immune Checkpoint Blockade: Mechanisms and Strategies.
Patel SA; Minn AJ
Immunity; 2018 Mar; 48(3):417-433. PubMed ID: 29562193
[TBL] [Abstract][Full Text] [Related]
13. New Mechanisms of Tumor-Associated Macrophages on Promoting Tumor Progression: Recent Research Advances and Potential Targets for Tumor Immunotherapy.
Guo Q; Jin Z; Yuan Y; Liu R; Xu T; Wei H; Xu X; He S; Chen S; Shi Z; Hou W; Hua B
J Immunol Res; 2016; 2016():9720912. PubMed ID: 27975071
[TBL] [Abstract][Full Text] [Related]
14. Role of m
Wu C; Li L; Tang Q; Liao Q; Chen P; Guo C; Zeng Z; Xiong W
Med Oncol; 2024 May; 41(6):159. PubMed ID: 38761335
[TBL] [Abstract][Full Text] [Related]
15. Chemokine-Directed Tumor Microenvironment Modulation in Cancer Immunotherapy.
Bule P; Aguiar SI; Aires-Da-Silva F; Dias JNR
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575965
[TBL] [Abstract][Full Text] [Related]
16. Overview of Basic Immunology for Clinical Investigators.
Stephen B; Hajjar J
Adv Exp Med Biol; 2017; 995():1-31. PubMed ID: 28321810
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-mesenchymal transition and inflammation at the site of the primary tumor.
Dominguez C; David JM; Palena C
Semin Cancer Biol; 2017 Dec; 47():177-184. PubMed ID: 28823497
[TBL] [Abstract][Full Text] [Related]
18. Regulatory T cell-mediated immunosuppression orchestrated by cancer: towards an immuno-genomic paradigm for precision medicine.
Kumagai S; Itahashi K; Nishikawa H
Nat Rev Clin Oncol; 2024 May; 21(5):337-353. PubMed ID: 38424196
[TBL] [Abstract][Full Text] [Related]
19. Exosomes promote pre-metastatic niche formation in ovarian cancer.
Feng W; Dean DC; Hornicek FJ; Shi H; Duan Z
Mol Cancer; 2019 Aug; 18(1):124. PubMed ID: 31409361
[TBL] [Abstract][Full Text] [Related]
20. How Tumor Cell Dedifferentiation Drives Immune Evasion and Resistance to Immunotherapy.
Li J; Stanger BZ
Cancer Res; 2020 Oct; 80(19):4037-4041. PubMed ID: 32554552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
